The Minute Virus of Mice: A New Hope for Pancreatic Cancer Treatment?

Pancreatic ductal carcinoma is one of the most aggressive cancers, often resistant to conventional treatments. Most patients are diagnosed at an advanced stage, rendering traditional therapies ineffective. Therefore, developing new therapeutic strategies is a priority to improve patient outcomes.  

Among promising approaches, oncolytic virotherapy, which uses modified viruses to destroy cancer cells, is gaining attention. Specifically, the minute virus of mice (MVMp), known for its tropism for cancer cells, may represent a novel strategy to target pancreatic tumors.